HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
XPNPEP3
X-prolyl aminopeptidase 3
Chromosome 22 Β· 22q13.2
NCBI Gene: 63929Ensembl: ENSG00000196236.13HGNC: HGNC:28052UniProt: A0A087X0Z2
65PubMed Papers
21Diseases
1Drugs
19Pathogenic Variants
FUNCTIONAL ROLE
Protease
CLINICAL
Clinical TrialsOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
glomerular filtrationprotein processingaminopeptidase activityprotein bindingnephronophthisis-like nephropathy 1nephronophthisislate-onset nephronophthisisbipolar disorder
✦AI Summary

XPNPEP3 is a mitochondrial X-prolyl aminopeptidase that functions primarily in mitochondrial protein homeostasis and ciliary biology. As an Xaa-Pro aminopeptidase, it cleaves peptides with proline at the second position (P1') and processes imported mitochondrial matrix proteins, leading to their stabilization 1. XPNPEP3 associates with respiratory chain complex I, where it is required for complex I stability and activity 2. Beyond enzymatic functions, XPNPEP3 serves as an adapter protein that promotes TNFRSF1B-mediated JNK phosphorylation independently of its peptidase activity, potentially inhibiting TNF-induced apoptosis. Clinically, XPNPEP3 mutations cause nephronophthisis-like nephropathy-1 (NPHPL1), a rare ciliopathy characterized by progressive cystic kidney disease 3. Mutations impair complex I function, ciliary length regulation, and predispose to tubular dilation and fibrosis under stress 2. XPNPEP3 deficiency disrupts mitochondrial proteostasis, compromising ATP production critical for high-energy tissues including cardiac muscle 4. Beyond kidney disease, XPNPEP3 represents an emerging link between mitochondrial dysfunction and ciliary pathology. XPNPEP3 expression dysregulation associates with depression and other neuropsychiatric disorders 56, and Wnt/Ξ²-catenin-driven upregulation promotes colorectal cancer tumorigenic properties 7.

Sources cited
1
XPNPEP3 is an Xaa-Pro aminopeptidase and processes mitochondrial matrix proteins
PMID: 28476889
2
XPNPEP3 is required for complex I stability and activity; its deletion causes ciliary elongation and predisposes to renal pathology
PMID: 37599822
3
XPNPEP3 mutations cause nephronophthisis-like nephropathy-1 (NPHPL1); protein localizes to mitochondria and has cilia-related function
PMID: 20179356
4
XPNPEP3 defects disrupt mitochondrial proteostasis and associate with cardiomyopathy
PMID: 35328774
5
XPNPEP3 expression dysregulation associates with depression risk
PMID: 34021117
6
Increased XPNPEP3 expression in prenatal brain associates with genetic risk for schizophrenia, bipolar disorder, and major depression
PMID: 32366953
7
XPNPEP3 is a transcriptional target of Wnt/Ξ²-catenin signaling; ectopic expression promotes colorectal cancer tumorigenic properties
PMID: 29383790
Disease Associationsβ“˜21
nephronophthisis-like nephropathy 1Open Targets
0.76Strong
nephronophthisisOpen Targets
0.48Moderate
late-onset nephronophthisisOpen Targets
0.37Weak
bipolar disorderOpen Targets
0.27Weak
genetic disorderOpen Targets
0.19Weak
kidney diseaseOpen Targets
0.18Weak
appendicitisOpen Targets
0.14Weak
alcohol drinkingOpen Targets
0.10Suggestive
refractive errorOpen Targets
0.10Suggestive
acute myeloid leukemiaOpen Targets
0.10Suggestive
myelodysplastic syndromeOpen Targets
0.10Suggestive
acute myeloid leukemia by FAB classificationOpen Targets
0.07Suggestive
neoplasmOpen Targets
0.05Suggestive
COVID-19Open Targets
0.03Suggestive
severe acute respiratory syndromeOpen Targets
0.03Suggestive
COVID-19–associated multisystem inflammatory syndrome in adultsOpen Targets
0.03Suggestive
vertebral column disorderOpen Targets
0.02Suggestive
esophageal squamous cell carcinomaOpen Targets
0.01Suggestive
colorectal cancerOpen Targets
0.01Suggestive
cerebellar ataxiaOpen Targets
0.01Suggestive
Nephronophthisis-like nephropathy 1UniProt
Pathogenic Variants19
NM_022098.4(XPNPEP3):c.499C>T (p.Arg167Ter)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 167
NM_022098.4(XPNPEP3):c.1357G>T (p.Gly453Cys)Pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 453
NM_022098.4(XPNPEP3):c.645del (p.Ser216fs)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 216
NM_022098.4(XPNPEP3):c.937_938del (p.Leu313fs)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 313
NM_022098.4(XPNPEP3):c.97del (p.Leu33fs)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 33
NM_022098.4(XPNPEP3):c.466C>T (p.Arg156Ter)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 156
NM_022098.4(XPNPEP3):c.589+1G>TLikely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024
NM_022098.4(XPNPEP3):c.760C>T (p.Arg254Ter)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 254
NM_022098.4(XPNPEP3):c.130C>T (p.Arg44Ter)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 44
NM_022098.4(XPNPEP3):c.250C>T (p.Gln84Ter)Pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024β†’ Residue 84
NM_022098.4(XPNPEP3):c.855+1G>ALikely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2024
NM_022098.4(XPNPEP3):c.658C>T (p.Gln220Ter)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2023β†’ Residue 220
NM_022098.4(XPNPEP3):c.1194_1200del (p.Asp398fs)Likely pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2023β†’ Residue 398
NM_022098.4(XPNPEP3):c.1055+2T>GLikely pathogenic
Nephronophthisis-like nephropathy 1|Papillary renal cell carcinoma type 1
β˜…β˜†β˜†β˜†2022
NM_022098.4(XPNPEP3):c.85C>T (p.Arg29Ter)Pathogenic
Nephronophthisis-like nephropathy 1
β˜…β˜†β˜†β˜†2022β†’ Residue 29
NM_022098.4(XPNPEP3):c.970-1G>ALikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_022098.4(XPNPEP3):c.720dup (p.Gln241fs)Pathogenic
Nephronophthisis-like nephropathy 1
β˜†β˜†β˜†β˜†2021β†’ Residue 241
NM_022098.4(XPNPEP3):c.1040G>A (p.Trp347Ter)Pathogenic
Nephronophthisis-like nephropathy 1
β˜†β˜†β˜†β˜†2021β†’ Residue 347
NM_022098.4(XPNPEP3):c.931_934del (p.Asn311fs)Pathogenic
Nephronophthisis-like nephropathy 1
β˜†β˜†β˜†β˜†2010β†’ Residue 311
View on ClinVar β†—
Drug Targets1
TOSEDOSTATPhase II
Aminopeptidase inhibitor
acute myeloid leukemia by FAB classification
Related Genes
XPNPEP2Protein interaction92%XPNPEP1Protein interaction89%ALMS1Protein interaction83%DNAAF1Protein interaction80%MIPEPProtein interaction74%CEP290Protein interaction74%
Tissue Expression6 tissues
Liver
100%
Heart
72%
Ovary
54%
Bone Marrow
37%
Lung
35%
Brain
34%
Gene Interaction Network
Click a node to explore
XPNPEP3XPNPEP2XPNPEP1ALMS1DNAAF1MIPEPCEP290
PROTEIN STRUCTURE
Preparing viewer…
PDB5X49 Β· 1.65 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.83LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.64 [0.49–0.83]
RankingsWhere XPNPEP3 stands among ~20K protein-coding genes
  • #7,228of 20,598
    Most Researched65
  • #2,239of 5,498
    Most Pathogenic Variants19
  • #7,096of 17,882
    Most Constrained (LOEUF)0.83
Genes detectedXPNPEP3
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Structure of the human aminopeptidase XPNPEP3 and comparison of its
PMID: 28476889
J Biol Chem Β· 2017
1.00
2
Mitochondrial Protein Homeostasis and Cardiomyopathy.
PMID: 35328774
Int J Mol Sci Β· 2022
0.90
3
Mutational burden of XPNPEP3 leads to defects in mitochondrial complex I and cilia in NPHPL1.
PMID: 37599822
iScience Β· 2023
0.80
4
Novel mutation in XPNPEP3 in a patient with heart failure without nephronophthisis-like nephropathy (NPHPL1): case report and literature review.
PMID: 39363162
BMC Pediatr Β· 2024
0.70
5
Individuals with mutations in XPNPEP3, which encodes a mitochondrial protein, develop a nephronophthisis-like nephropathy.
PMID: 20179356
J Clin Invest Β· 2010
0.60